{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:18:42Z","timestamp":1792523922460,"version":"4.5.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFA1800401"],"award-info":[{"award-number":["2023YFA1800401"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020732","name":"Innovative Research Team of High-level Local University in Shanghai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82570200"],"award-info":[{"award-number":["82570200"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400180"],"award-info":[{"award-number":["82400180"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82350710226"],"award-info":[{"award-number":["82350710226"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370178"],"award-info":[{"award-number":["82370178"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bcp.2026.118490","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T23:27:55Z","timestamp":1789860475000},"page":"118490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P2","title":["IRF1-driven chromatin and transcriptional regulation determines the anti-tumor responses to all-trans retinoic acid across cancer types"],"prefix":"10.1016","volume":"254","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5084-2076","authenticated-orcid":false,"given":"Wen","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacheng","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfen","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaner","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kankan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118490_b0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1470-2045(00)00017-6","article-title":"Differentiation and apoptosis induction therapy in acute promyelocytic leukaemia","volume":"1","author":"Wang","year":"2000","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bcp.2026.118490_b0010","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood-2016-02-699439","article-title":"The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia","volume":"128","author":"Zhu","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.118490_b0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/35106036","article-title":"The promise of retinoids to fight against cancer","volume":"1","author":"Altucci","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2026.118490_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12080707","article-title":"Current Trends in ATRA delivery for Cancer Therapy","volume":"12","author":"Giuli","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2026.118490_b0025","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1182\/blood-2007-07-102798","article-title":"Acute promyelocytic leukemia: from highly fatal to highly curable","volume":"111","author":"Wang","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.118490_b0030","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/sj.onc.1202075","article-title":"Targeting the PML\/RAR alpha translocation product triggers apoptosis in promyelocytic leukemia cells","volume":"17","author":"Nason-Burchenal","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.118490_b0035","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1089\/hum.2011.079","article-title":"Targeting expression of the leukemogenic PML-RARalpha fusion protein by lentiviral vector-mediated small interfering RNA results in leukemic cell differentiation and apoptosis","volume":"22","author":"Ward","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bcp.2026.118490_b0040","article-title":"All-trans retinoic acid in hematologic disorders: not just acute promyelocytic leukemia","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118490_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051169","article-title":"All-Trans Retinoic Acid Stimulates Viral Mimicry, Interferon responses and Antigen Presentation in Breast-Cancer Cells","volume":"12","author":"Bolis","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2026.118490_b0050","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cell.2020.11.045","article-title":"A modular master regulator landscape controls cancer transcriptional identity","author":"Paull","year":"2021","journal-title":"Cell 184"},{"key":"10.1016\/j.bcp.2026.118490_b0055","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/tpj.2013.39","article-title":"Data mining reveals a network of early-response genes as a consensus signature of drug-induced in vitro and in vivo toxicity","volume":"14","author":"Zhang","year":"2014","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.bcp.2026.118490_b0060","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1073\/pnas.0502825102","article-title":"Systems analysis of transcriptome and proteome in retinoic acid\/arsenic trioxide-induced cell differentiation\/apoptosis of promyelocytic leukemia","volume":"102","author":"Zheng","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2026.118490_b0065","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1525-1578(10)60476-X","article-title":"Gene expression profiling during all-trans retinoic acid-induced cell differentiation of acute promyelocytic leukemia cells","volume":"5","author":"Yang","year":"2003","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.bcp.2026.118490_b0070","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1182\/blood.V96.4.1496","article-title":"Gene expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells","volume":"96","author":"Liu","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.118490_b0075","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1124\/jpet.117.240523","article-title":"Physiologically based Pharmacokinetic Model of All-trans-Retinoic Acid with Application to Cancer Populations and Drug Interactions","volume":"361","author":"Jing","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2026.118490_b0080","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood.V79.2.299.299","article-title":"Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid \u201cresistance\u201d in patients with acute promyelocytic leukemia","volume":"79","author":"Muindi","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.118490_b0085","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1073\/pnas.0400053101","article-title":"All-trans retinoic acid\/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia","volume":"101","author":"Shen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2026.118490_b0090","doi-asserted-by":"crossref","first-page":"e1431","DOI":"10.1038\/cddis.2014.388","article-title":"Transcriptional repression of CDKN2D by PML\/RARalpha contributes to the altered proliferation and differentiation block of acute promyelocytic leukemia cells","volume":"5","author":"Wang","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.118490_b0095","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ccr.2009.12.045","article-title":"PML\/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia","volume":"17","author":"Wang","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2026.118490_b0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1756-8722-6-25","article-title":"Structurally differentiated cis-elements that interact with PU.1 are functionally distinguishable in acute promyelocytic leukemia","volume":"6","author":"Qian","year":"2013","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2026.118490_b0105","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1182\/blood.2020005698","article-title":"A PML\/RARalpha direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia","volume":"137","author":"Tan","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.118490_b0110","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.3324\/haematol.2021.280147","article-title":"Interplay between hypertriglyceridemia and acute promyelocytic leukemia mediated by the cooperation of peroxisome proliferator-activated receptor-alpha with the PML\/RAR alpha fusion protein on super-enhancers","volume":"107","author":"Wu","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.bcp.2026.118490_b0115","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bcp.2026.118490_b0120","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bcp.2026.118490_b0125","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","article-title":"Model-based analysis of ChIP-Seq (MACS)","volume":"9","author":"Zhang","year":"2008","journal-title":"Genome Biol."},{"key":"10.1016\/j.bcp.2026.118490_b0130","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/nprot.2012.101","article-title":"Identifying ChIP-seq enrichment using MACS","volume":"7","author":"Feng","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bcp.2026.118490_b0135","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","article-title":"Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities","volume":"38","author":"Heinz","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2026.118490_b0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature11232","article-title":"The accessible chromatin landscape of the human genome","volume":"489","author":"Thurman","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118490_b0145","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood-2011-10-386086","article-title":"Chromatin accessibility, p300, and histone acetylation define PML-RARalpha and AML1-ETO binding sites in acute myeloid leukemia","volume":"120","author":"Saeed","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.118490_b0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","author":"E.P. Consortium","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118490_b0155","doi-asserted-by":"crossref","first-page":"7403","DOI":"10.1158\/0008-5472.CAN-05-0583","article-title":"Signaling through IFN regulatory factor-5 sensitizes p53-deficient tumors to DNA damage-induced apoptosis and cell death","volume":"65","author":"Hu","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118490_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105078","article-title":"An integrative pan-cancer analysis of the molecular characteristics of dietary restriction in tumour microenvironment","volume":"102","author":"Song","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bcp.2026.118490_b0165","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/s41467-024-45737-7","article-title":"Cellular hierarchy insights reveal leukemic stem-like cells and early death risk in acute promyelocytic leukemia","volume":"15","author":"Jin","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118490_b0170","doi-asserted-by":"crossref","DOI":"10.1093\/gpbjnl\/qzaf005","article-title":"Resolving Leukemia Heterogeneity and Lineage Aberrations with HematoMap","volume":"23","author":"Dai","year":"2025","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.bcp.2026.118490_b0175","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1182\/blood-2010-03-276196","article-title":"Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group","volume":"116","author":"Lo-Coco","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.118490_b0180","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0167-4781(99)00078-0","article-title":"Interferon regulatory factor 1 tryptophan 11 to arginine point mutation abolishes DNA binding","volume":"1446","author":"Eason","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2026.118490_b0185","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1182\/blood-2018-99-112978","article-title":"The Genes for Tissue factor F3 and Nuclear Receptor 4A are Down-Regulated in Early Death Acute Promyelocytic Leukemia patients","volume":"132","author":"Frech","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.118490_b0190","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1158\/0008-5472.CAN-06-3564","article-title":"Tumor suppression by IFN regulatory factor-1 is mediated by transcriptional down-regulation of cyclin D1","volume":"67","author":"Kroger","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118490_b0195","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/nar\/gkn1051","article-title":"A ChIP-chip approach reveals a novel role for transcription factor IRF1 in the DNA damage response","volume":"37","author":"Frontini","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2026.118490_b0200","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1182\/blood-2006-11-059048","article-title":"RNAi screen identifies UBE2D3 as a mediator of all-trans retinoic acid-induced cell growth arrest in human acute promyelocytic NB4 cells","volume":"110","author":"Hattori","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.118490_b0205","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/cdd.2014.175","article-title":"Involvement of RARRES3 in the regulation of Wnt proteins acylation and signaling activities in human breast cancer cells","volume":"22","author":"Hsu","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2026.118490_b0210","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/35007091","article-title":"ATM phosphorylates p95\/nbs1 in an S-phase checkpoint pathway","volume":"404","author":"Lim","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118490_b0215","first-page":"2670","article-title":"BCAT1 knockdown-mediated suppression of melanoma cell proliferation and migration is associated with reduced oxidative phosphorylation","volume":"11","author":"Zhang","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118490_b0220","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1038\/onc.2013.224","article-title":"Coordinated regulation of the immunoproteasome subunits by PML\/RARalpha and PU.1 in acute promyelocytic leukemia","volume":"33","author":"Yang","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.118490_b0225","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.4049\/jimmunol.1900475","article-title":"Frequent loss of IRF2 in Cancers leads to Immune Evasion through Decreased MHC Class I Antigen Presentation and increased PD-L1 Expression","volume":"203","author":"Kriegsman","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2026.118490_b0230","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.molimm.2017.12.025","article-title":"IRF1 up-regulates isg15 gene expression in dsRNA stimulation or CSFV infection by targeting nucleotides -487 to -325 in the 5' flanking region","volume":"94","author":"Li","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bcp.2026.118490_b0235","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1073\/pnas.052011299","article-title":"UBE1L is a retinoid target that triggers PML\/RARalpha degradation and apoptosis in acute promyelocytic leukemia","volume":"99","author":"Kitareewan","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2026.118490_b0240","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/1878-0261.12614","article-title":"Inhibition of UBE2L6 attenuates ISGylation and impedes ATRA-induced differentiation of leukemic cells","volume":"14","author":"Orfali","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bcp.2026.118490_b0245","doi-asserted-by":"crossref","first-page":"14395","DOI":"10.1073\/pnas.1918596117","article-title":"RIG-I regulates myeloid differentiation by promoting TRIM25-mediated ISGylation","volume":"117","author":"Wu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2026.118490_b0250","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1038\/sj.onc.1204854","article-title":"Role and fate of PML nuclear bodies in response to interferon and viral infections","volume":"20","author":"Regad","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.118490_b0255","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1189\/jlb.3CE0116-030R","article-title":"Editorial: an ATRA oddity: new questions revealed on retinoid synthesis in bone marrow cells","volume":"99","author":"Pelletier","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcp.2026.118490_b0260","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.3324\/haematol.13096","article-title":"Accumulation of hypoxia-inducible factor-1 alpha protein and its role in the differentiation of myeloid leukemic cells induced by all-trans retinoic acid","volume":"93","author":"Zhang","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bcp.2026.118490_b0265","first-page":"3163","article-title":"Retinoic acid induced mitogen-activated protein (MAP)\/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest","volume":"58","author":"Yen","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118490_b0270","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/bjh.70057","article-title":"Synergistic potential of CDK4\/6 inhibitors and ATRA in non-APL AML","volume":"207","author":"Skopek","year":"2025","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcp.2026.118490_b0275","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/sj.leu.2403773","article-title":"The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells","volume":"19","author":"Trus","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2026.118490_b0280","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.thromres.2011.03.006","article-title":"All trans-retinoic acid modulates the procoagulant activity of human breast cancer cells","volume":"128","author":"Marchetti","year":"2011","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bcp.2026.118490_b0285","doi-asserted-by":"crossref","DOI":"10.3390\/cells14100746","article-title":"All-Trans Retinoic Acid Induces Differentiation and Downregulates Stemness Markers and MGMT Expression in Glioblastoma Stem Cells","volume":"14","author":"Tang","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2026.118490_b0290","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1476-4598-10-136","article-title":"Retinoic acid pathway activity in Wilms tumors and characterization of biological responses in vitro","volume":"10","author":"Wegert","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2026.118490_b0295","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00001813-199706000-00016","article-title":"The additive antiproliferative effect of all-trans retinoic acid and interferon-alpha2a on human cervical carcinoma cell lines is not associated with increased expression of retinoid receptors","volume":"8","author":"Wahlberg","year":"1997","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.bcp.2026.118490_b0300","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1158\/0008-5472.CAN-03-2848","article-title":"Inhibitory effect of 12-O-tetradecanoylphorbol-13-acetate alone or in combination with all-trans-retinoic acid on the growth of LNCaP prostate tumors in immunodeficient mice","volume":"64","author":"Zheng","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118490_b0305","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13046-023-02869-w","article-title":"Anti-tumor activity of all-trans retinoic acid in gastric-cancer: gene-networks and molecular mechanisms","volume":"42","author":"Guarrera","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118490_b0310","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2211429119","article-title":"Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia","volume":"119","author":"Cheng","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2026.118490_b0315","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0145-2126(01)00202-8","article-title":"Human B-cell lymphoma cell lines are highly sensitive to apoptosis induced by all-trans retinoic acid and interferon-gamma","volume":"26","author":"Niitsu","year":"2002","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bcp.2026.118490_b0320","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbaexp.2005.08.006","article-title":"Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity","volume":"1731","author":"Giuliano","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2026.118490_b0325","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2147\/CMAR.S32449","article-title":"Retinoids in the treatment of glioma: a new perspective","volume":"4","author":"Mawson","year":"2012","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.bcp.2026.118490_b0330","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171672","article-title":"Interferon regulatory factor 1 inactivation in human cancer","volume":"38","author":"Alsamman","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bcp.2026.118490_b0335","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/107999002753452610","article-title":"Activities of IRF-1","volume":"22","author":"Kroger","year":"2002","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.bcp.2026.118490_b0340","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/107999002753452647","article-title":"IRF-1 as a negative regulator of cell proliferation","volume":"22","author":"Romeo","year":"2002","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.bcp.2026.118490_b0345","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1182\/blood.V88.1.114.114","article-title":"Retinoic acid activates interferon regulatory factor-1 gene expression in myeloid cells","volume":"88","author":"Matikainen","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.118490_b0350","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1038\/s41388-022-02505-5","article-title":"A novel network pharmacology approach for leukaemia differentiation therapy using Mogrify\u00ae","volume":"41","author":"Lee","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.118490_b0355","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.gene.2016.12.029","article-title":"Identification of an IRF-1 splicing transcript in APL cells sharing similar transactivation activity of the full length one","volume":"605","author":"Lou","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.bcp.2026.118490_b0360","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.3109\/10428194.2011.603449","article-title":"Interferon regulatory factor-1 binds c-Cbl, enhances mitogen activated protein kinase signaling and promotes retinoic acid-induced differentiation of HL-60 human myelo-monoblastic leukemia cells","volume":"52","author":"Shen","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bcp.2026.118490_b0365","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1053\/j.gastro.2005.12.017","article-title":"All-trans retinoic acid induces XAF1 expression through an interferon regulatory factor-1 element in colon cancer","volume":"130","author":"Wang","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2026.118490_b0370","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1182\/blood.2020009856","article-title":"RARgamma activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway","volume":"139","author":"Wang","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.118490_b0375","doi-asserted-by":"crossref","first-page":"16684","DOI":"10.1038\/s41598-017-16687-6","article-title":"Profiling of the transcriptional response to all-trans retinoic acid in breast cancer cells reveals RARE-independent mechanisms of gene expression","volume":"7","author":"Coyle","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.118490_b0380","article-title":"Phase separation of PML\/RARalpha and BRD4 coassembled microspeckles governs transcriptional dysregulation in acute promyelocytic leukemia","volume":"121","author":"Zhang","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2026.118490_b0385","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1158\/2159-8290.CD-17-0399","article-title":"Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARalpha Dependency Targetable by SY-1425, a Potent and Selective RARalpha Agonist","volume":"7","author":"McKeown","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bcp.2026.118490_b0390","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1038\/bjc.2014.412","article-title":"Unlocking the potential of retinoic acid in anticancer therapy","volume":"111","author":"Schenk","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2026.118490_b0395","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15143535","article-title":"The Promise of Retinoids in the Treatment of Cancer: neither Burnt out nor Fading away","volume":"15","author":"Nagai","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2026.118490_b0400","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12964-024-01492-2","article-title":"Cellular and micro-environmental responses influencing the antitumor activity of all-trans retinoic acid in breast cancer","volume":"22","author":"Caricasulo","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bcp.2026.118490_b0405","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1254612","article-title":"Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers","volume":"11","author":"Lavudi","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2026.118490_b0410","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1194\/jlr.M067447","article-title":"ATRA transcriptionally induces nSMase2 through CBP\/p300-mediated histone acetylation","volume":"57","author":"Clarke","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bcp.2026.118490_b0415","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.blre.2015.01.002","article-title":"An ATRActive future for differentiation therapy in AML","volume":"29","author":"Johnson","year":"2015","journal-title":"Blood Rev."},{"key":"10.1016\/j.bcp.2026.118490_b0420","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/415187a","article-title":"Co-regulator recruitment and the mechanism of retinoic acid receptor synergy","volume":"415","author":"Germain","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118490_b0425","doi-asserted-by":"crossref","first-page":"950","DOI":"10.15252\/emmm.201404670","article-title":"Cellular and molecular determinants of all-trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RARalpha expression","volume":"7","author":"Centritto","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bcp.2026.118490_b0430","doi-asserted-by":"crossref","first-page":"16448","DOI":"10.1073\/pnas.0607830103","article-title":"RIG-G as a key mediator of the antiproliferative activity of interferon-related pathways through enhancing p21 and p27 proteins","volume":"103","author":"Xiao","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2026.118490_b0435","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/annonc\/mdw660","article-title":"Network-guided modeling allows tumor-type independent prediction of sensitivity to all-trans-retinoic acid","volume":"28","author":"Bolis","year":"2017","journal-title":"Ann. Oncol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226008324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:18:16Z","timestamp":1790803096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226008324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":87,"alternative-id":["S0006295226008324"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118490","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IRF1-driven chromatin and transcriptional regulation determines the anti-tumor responses to all-trans retinoic acid across cancer types","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118490"}}